Safety and Efficacy of Combined Chelation Therapy with Deferasirox and Deferoxamine in a Gerbil Model of Iron Overload

Publisher： Karger

E-ISSN： 1421-9662|120|2|123-128

ISSN： 0001-5792

Source： Acta Haematologica, Vol.120, Iss.2, 2008-11, pp. : 123-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox

By  

Acta Haematologica, Vol. 123, Iss. 3, 2010-02 ,pp. : 148-152

Karger

Access to resources Recommend Favorite

Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients

By  

Acta Haematologica, Vol. 128, Iss. 2, 2012-06 ,pp. : 113-118

Karger

Access to resources Recommend Favorite

Antioxidant-Mediated Effects in a Gerbil Model of Iron Overload

By  

Acta Haematologica, Vol. 118, Iss. 4, 2007-10 ,pp. : 193-199

Karger

Access to resources Recommend Favorite

Acute iron intoxication: change in urine color during chelation therapy with deferoxamine

By Fernández Sara   Castro Pedro   Nogué Santiago   Nicolás Jose  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 104-104

Springer Publishing Company

Access to resources Recommend Favorite

Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia

By  

Acta Haematologica, Vol. 129, Iss. 2, 2012-11 ,pp. : 72-77

Karger

Access to resources Recommend Favorite